SUCCESSFUL SALVAGE USING MISMATCHED UMBILICAL-CORD BLOOD TRANSPLANT IN AN ADULT WITH RECURRENT ACUTE MYELOGENOUS LEUKEMIA FAILING AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANT - A CASE-HISTORY AND REVIEW
Vg. Gian et al., SUCCESSFUL SALVAGE USING MISMATCHED UMBILICAL-CORD BLOOD TRANSPLANT IN AN ADULT WITH RECURRENT ACUTE MYELOGENOUS LEUKEMIA FAILING AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANT - A CASE-HISTORY AND REVIEW, Bone marrow transplantation, 21(12), 1998, pp. 1197-1200
We report a 26-year-old female with AML, FAB classification M5 who was
initially treated with induction therapy consisting of idarubicin and
cytarabine followed by high-dose cytarabine and autologous peripheral
blood progenitor cell (PBPC) transplant for consolidation. The patien
t remained in remission for 1 month post-PBPC transplant, when relapse
was noted. Reinduction therapy with idarubicin, cytarabine and etopos
ide was unsuccessful, and the patient underwent an unrelated, two-anti
gen mismatched umbilical cord blood (UCB) transplant for salvage after
melphalan plus total body irradiation. Complications post transplant
included veno-occlusive disease, delayed engraftment, and acute grade
III graft-versus-host disease (GVHD). The patient remains in remission
1 year post transplant. This study demonstrates the salvage capabilit
y of UCB transplantation for refractory leukemia and its potential use
in adult patients.